Diana Hausman, Chief Medical Officer at Zymeworks Inc. (ZYME), sold 37,235 shares at $55.19 ($2.1M) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $2.1M ZYME by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.19 | 18,267 | $1.0M | 49.1% |
| 2 | $55.19 | 18,267 | $1.0M | 49.1% |
| 3 | $55.01 | 701 | $39K | 1.9% |
| Total | $55.19 avg | 37,235 | $2.1M | 100% |
| Filing → |
| ZYME | SELL | 2021-03-12 | $37K | — | Filing → |
| ZYME | SELL | 2020-12-04 | $665K | — | Filing → |
| ZYME | SELL | 2020-09-16 | $1.8M | — | Filing → |